AG-636
N/A
Report date: 2023/08/11 20:00:52
NME
Base Information
Drug NameAG-636
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAgios Pharmaceuticals IncLaboratoires ServierAurigene Discovery Technologies Ltd
China Registration ClassN/A
Develop Information
Active CompaniesAurigene Discovery Technologies LtdServier Pharmaceuticals Llc
Inactive CompaniesAgios Pharmaceuticals Inc
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A